Cargando…
A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases
BACKGROUND: Regulatory T cells (Tregs) can alleviate the development of autoimmune and inflammatory diseases, thereby proposing their role as a new therapeutic strategy. Parasitic helminths have co-evolved with hosts to generate immunological privilege and immune tolerance through inducing Tregs. Th...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448429/ https://www.ncbi.nlm.nih.gov/pubmed/37579625 http://dx.doi.org/10.1016/j.ebiom.2023.104751 |
_version_ | 1785094731575853056 |
---|---|
author | Ni, Yangyue Xiong, Ruiyan Zhu, Yuxiao Luan, Ning Yu, Chuanxin Yang, Kun Wang, Huiquan Xu, Xuejun Yang, Yuxuan Sun, Siyu Shi, Liyun Padde, Jon Rob Chen, Lin Chen, Lu Hou, Min Xu, Zhipeng Lai, Ren Ji, Minjun |
author_facet | Ni, Yangyue Xiong, Ruiyan Zhu, Yuxiao Luan, Ning Yu, Chuanxin Yang, Kun Wang, Huiquan Xu, Xuejun Yang, Yuxuan Sun, Siyu Shi, Liyun Padde, Jon Rob Chen, Lin Chen, Lu Hou, Min Xu, Zhipeng Lai, Ren Ji, Minjun |
author_sort | Ni, Yangyue |
collection | PubMed |
description | BACKGROUND: Regulatory T cells (Tregs) can alleviate the development of autoimmune and inflammatory diseases, thereby proposing their role as a new therapeutic strategy. Parasitic helminths have co-evolved with hosts to generate immunological privilege and immune tolerance through inducing Tregs. Thus, constructing a “Tregs-induction”-based discovery pipeline from parasitic helminth is a promising strategy to control autoimmune and inflammatory diseases. METHODS: The gel filtration chromatography and reverse-phase high-performance liquid chromatography (RP-HPLC) were used to isolate immunomodulatory components from the egg extracts of Schistosoma japonicum. The extracted peptides were evaluated for their effects on Tregs suppressive functions using flow cytometry, ELISA and T cell suppression assay. Finally, we carried out colitis and psoriasis models to evaluate the function of Tregs induced by helminth-derived peptide in vivo. FINDINGS: Here, based on target-driven discovery strategy, we successfully identified a small 3 kDa peptide (SjDX5-53) from egg extracts of schistosome, which promoted both human and murine Tregs production. SjDX5-53 presented immunosuppressive function by arresting dendritic cells (DCs) at an immature state and augmenting the proportion and suppressive capacity of Tregs. In mouse models, SjDX5-53 protected mice against autoimmune-related colitis and psoriasis through inducing Tregs and inhibiting inflammatory T-helper (Th) 1 and Th17 responses. INTERPRETATION: SjDX5-53 exhibited the promising therapeutic effects in alleviating the phenotype of immune-related colitis and psoriasis. This study displayed a screening and validation pipeline of the inducer of Tregs from helminth eggs, highlighting the discovery of new biologics inspired by co-evolution of hosts and their parasites. FUNDING: This study was supported by the 10.13039/501100001809Natural Science Foundation of China (82272368) and 10.13039/501100004608Natural Science Foundation of Jiangsu Province (BK20211586). |
format | Online Article Text |
id | pubmed-10448429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-104484292023-08-25 A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases Ni, Yangyue Xiong, Ruiyan Zhu, Yuxiao Luan, Ning Yu, Chuanxin Yang, Kun Wang, Huiquan Xu, Xuejun Yang, Yuxuan Sun, Siyu Shi, Liyun Padde, Jon Rob Chen, Lin Chen, Lu Hou, Min Xu, Zhipeng Lai, Ren Ji, Minjun eBioMedicine Articles BACKGROUND: Regulatory T cells (Tregs) can alleviate the development of autoimmune and inflammatory diseases, thereby proposing their role as a new therapeutic strategy. Parasitic helminths have co-evolved with hosts to generate immunological privilege and immune tolerance through inducing Tregs. Thus, constructing a “Tregs-induction”-based discovery pipeline from parasitic helminth is a promising strategy to control autoimmune and inflammatory diseases. METHODS: The gel filtration chromatography and reverse-phase high-performance liquid chromatography (RP-HPLC) were used to isolate immunomodulatory components from the egg extracts of Schistosoma japonicum. The extracted peptides were evaluated for their effects on Tregs suppressive functions using flow cytometry, ELISA and T cell suppression assay. Finally, we carried out colitis and psoriasis models to evaluate the function of Tregs induced by helminth-derived peptide in vivo. FINDINGS: Here, based on target-driven discovery strategy, we successfully identified a small 3 kDa peptide (SjDX5-53) from egg extracts of schistosome, which promoted both human and murine Tregs production. SjDX5-53 presented immunosuppressive function by arresting dendritic cells (DCs) at an immature state and augmenting the proportion and suppressive capacity of Tregs. In mouse models, SjDX5-53 protected mice against autoimmune-related colitis and psoriasis through inducing Tregs and inhibiting inflammatory T-helper (Th) 1 and Th17 responses. INTERPRETATION: SjDX5-53 exhibited the promising therapeutic effects in alleviating the phenotype of immune-related colitis and psoriasis. This study displayed a screening and validation pipeline of the inducer of Tregs from helminth eggs, highlighting the discovery of new biologics inspired by co-evolution of hosts and their parasites. FUNDING: This study was supported by the 10.13039/501100001809Natural Science Foundation of China (82272368) and 10.13039/501100004608Natural Science Foundation of Jiangsu Province (BK20211586). Elsevier 2023-08-12 /pmc/articles/PMC10448429/ /pubmed/37579625 http://dx.doi.org/10.1016/j.ebiom.2023.104751 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Ni, Yangyue Xiong, Ruiyan Zhu, Yuxiao Luan, Ning Yu, Chuanxin Yang, Kun Wang, Huiquan Xu, Xuejun Yang, Yuxuan Sun, Siyu Shi, Liyun Padde, Jon Rob Chen, Lin Chen, Lu Hou, Min Xu, Zhipeng Lai, Ren Ji, Minjun A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases |
title | A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases |
title_full | A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases |
title_fullStr | A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases |
title_full_unstemmed | A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases |
title_short | A target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases |
title_sort | target-based discovery from a parasitic helminth as a novel therapeutic approach for autoimmune diseases |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448429/ https://www.ncbi.nlm.nih.gov/pubmed/37579625 http://dx.doi.org/10.1016/j.ebiom.2023.104751 |
work_keys_str_mv | AT niyangyue atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT xiongruiyan atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT zhuyuxiao atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT luanning atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT yuchuanxin atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT yangkun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT wanghuiquan atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT xuxuejun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT yangyuxuan atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT sunsiyu atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT shiliyun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT paddejonrob atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT chenlin atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT chenlu atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT houmin atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT xuzhipeng atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT lairen atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT jiminjun atargetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT niyangyue targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT xiongruiyan targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT zhuyuxiao targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT luanning targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT yuchuanxin targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT yangkun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT wanghuiquan targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT xuxuejun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT yangyuxuan targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT sunsiyu targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT shiliyun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT paddejonrob targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT chenlin targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT chenlu targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT houmin targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT xuzhipeng targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT lairen targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases AT jiminjun targetbaseddiscoveryfromaparasitichelminthasanoveltherapeuticapproachforautoimmunediseases |